Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-054776
Filing Date
2025-04-16
Accepted
2025-04-16 16:30:36
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A catx-20250415.htm   iXBRL DEF 14A 1152149
2 GRAPHIC img243948980_0.jpg GRAPHIC 45893
3 GRAPHIC img243948980_1.jpg GRAPHIC 44451
4 GRAPHIC img243948980_2.jpg GRAPHIC 477649
5 GRAPHIC img243948980_3.jpg GRAPHIC 476700
  Complete submission text file 0000950170-25-054776.txt   4731276

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250415.xsd EX-101.SCH 13841
19 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250415_htm.xml XML 446650
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33407 | Film No.: 25843178
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)